J0578 Inj brixadi, more than 7 day
Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
- Medicare coverage: Carrier judgment
- Status: active (July 2026 file)
- MUE: max 1 units per day (practitioner), rationale: Prescribing Information